These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35261071)

  • 21. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.
    de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of the small adenoma: a longitudinal study of surveillance colonoscopy in an Australian population.
    Symonds EL; Cole SR; Lau SY; Steele S; Meng R; Woodman RJ; Young GP; Cock C; Fraser R; Bampton P
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):563-569. PubMed ID: 30672827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas.
    Lee JK; Roy A; Jensen CD; Chan JT; Zhao WK; Levin TR; Chubak J; Halm EA; Skinner CS; Schottinger JE; Ghai NR; Burnett-Hartman AN; Kamineni A; Udaltsova N; Corley DA
    JAMA Netw Open; 2024 Apr; 7(4):e244611. PubMed ID: 38564216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk stratification of advanced colorectal neoplasia after baseline colonoscopy: Cohort study of 17 Japanese community practices.
    Shono T; Oyama S; Oda Y; Yokomine K; Murakami Y; Miyamoto H; Tanaka M; Naoe H; Sasaki Y;
    Dig Endosc; 2020 Jan; 32(1):106-113. PubMed ID: 31429986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term cumulative incidence of metachronous advanced colorectal neoplasia after colonoscopy and a novel risk factor: a cohort study.
    Omata F; Deshpande GA; Suzuki H; Hayashi K; Ishii N; Matoba K; Ohmuro A; Rai F; Takashima M; Fukuda K; Masuda K; Kumakura Y
    Eur J Gastroenterol Hepatol; 2021 Nov; 33(11):1341-1347. PubMed ID: 34402471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ideal colonoscopic surveillance intervals to reduce incidence of advanced adenoma and colorectal cancer.
    Good NM; Macrae FA; Young GP; O'Dywer J; Slattery M; Venables W; Lockett TJ; O'Dwyer M
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1147-54. PubMed ID: 25611802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
    Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
    Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
    Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
    BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
    Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age- and sex-stratified detection rates and associated factors of colorectal neoplasia in the Tianjin colorectal cancer screening program from 2012 to 2020.
    Yuan Z; Wang S; Wang Y; Li H; Gao W; Liu X; Han Y; Liu Z; Zhang Q; Ma H; Wang J; Wei X; Zhang X; Cui W; Zhang C
    BMC Gastroenterol; 2023 Dec; 23(1):435. PubMed ID: 38087194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk stratification for advanced colorectal neoplasia based on the findings of the index and first surveillance colonoscopies.
    Honda M; Naoe H; Gushima R; Miyamoto H; Tateyama M; Sakurai K; Oda Y; Murakami Y; Tanaka Y
    PLoS One; 2021; 16(1):e0245211. PubMed ID: 33481809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
    Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
    Gastrointest Endosc; 2018 Jul; 88(1):128-135. PubMed ID: 29510145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
    Green T; Richardson A; Parry S
    N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoplasia at 10-year follow-up screening colonoscopy in a private U.S. practice: comparison of yield to first-time examinations.
    Rex DK; Ponugoti PL; Johnson CS; Kittner L; Yanda RJ
    Gastrointest Endosc; 2018 Jan; 87(1):254-259. PubMed ID: 28478026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
    Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Based Screening : A Population-Based Cohort Study.
    Wisse PHA; Erler NS; de Boer SY; den Hartog B; Oudkerk Pool M; Terhaar Sive Droste JS; Verveer C; Meijer GA; Lansdorp-Vogelaar I; Kuipers EJ; Dekker E; Spaander MCW
    Ann Intern Med; 2022 Oct; 175(10):1366-1373. PubMed ID: 36162114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
    Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
    Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.